Safety and Effectiveness of Emricasan Versus Placebo in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis: An Updated Systematic Review and Meta-Analysis.

emricasan (IDN 6556) - Amerimmune

http://www.ncbi.nlm.nih.gov/pubmed/40525863

Venjhraj; Abdul Moeed; Haniya Shahid; Khalid Ahmad; Mohammad Zamrood Khan; Muhammad Ahmed; Muhammad Safwan; Mukesh Kumar; Muzna Murtaza; Shah Muhammad Zulqarnain; Zainab Muhammad Hanif

Jun 17, 2025